Creo Medical (GB:CREO) has released an update.
Creo Medical Group, a leader in minimally invasive surgical technologies, announced that its CFO, Richard Rees, executed a ‘Bed and ISA’ transaction involving 174,740 company shares. This strategic move, alongside a purchase by Rachel Rees, effectively maintains their shareholding while optimizing tax efficiency, reflecting potential confidence in the company’s growth prospects.
For further insights into GB:CREO stock, check out TipRanks’ Stock Analysis page.
